Morgan Stanley Reiterates Equal-Weight on Johnson & Johnson, Maintains $187 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn has reiterated an Equal-Weight rating on Johnson & Johnson (NYSE:JNJ) and maintained a price target of $187.
July 21, 2023 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has reiterated an Equal-Weight rating on Johnson & Johnson and maintained a price target of $187.
The news is directly related to Johnson & Johnson and is likely to influence investor sentiment. However, as the rating and price target have been maintained, the immediate impact on the stock price is expected to be neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100